Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business day
Get my quote

Severe combined immunodeficiency (SCID): US-approved treatments and how Gulf families can access them

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Severe combined immunodeficiency (SCID): the short answer

The US FDA has approved one medicine on this page for severe combined immunodeficiency (SCID), each for specific patients. None was found on the Gulf registers we checked. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

  • US FDA-approved medicines on this page: Revcovi.
  • Gulf registration (checked 17 October 2026): see each medicine below.
  • Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
  • Price: Quote on request.

What is severe combined immunodeficiency (SCID)?

Severe combined immunodeficiency (SCID) is a group of inherited disorders in which babies lack the immune cells needed to fight bacteria, viruses and fungi. Without treatment, infants develop poor growth, chronic diarrhea, thrush, skin rashes and life-threatening infections.[1]

SCID has several genetic causes. X-linked SCID affects almost only boys. Adenosine deaminase (ADA) deficiency causes SCID in about 80 percent of people with that enzyme deficiency, and these babies usually develop health problems in the first 6 months of life.[1, 2]

SCID can be detected shortly after birth by newborn screening, which allows prompt treatment, often a stem cell transplant. In the US, an enzyme replacement therapy is approved for ADA-SCID.[1, 3]

Severe combined immunodeficiency (SCID) in the Gulf

The Kuwait National Primary Immunodeficiency Registry recorded 314 patients from 2004 to 2018. Disorders affecting cellular and humoral immunity, the group that includes SCID, were the largest category (31.8%), and the average delay in diagnosis was 27 months.[4]

US FDA-approved medicines for severe combined immunodeficiency (SCID)

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

  • Revcovi (elapegademase-lvlr)
    FDA-approved for adenosine deaminase severe combined immune deficiency (ADA-SCID) in children and adults. It is an enzyme replacement given by injection into the muscle.[3]
    Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[5, 6]

How families in the Gulf can access these medicines

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[7, 8] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

Who does what

  • Your treating specialist decides whether a medicine is right for the patient and writes the letter.
  • The hospital checks local supply, files any import request, and gives the treatment safely.
  • The national regulator decides whether to approve the import of a medicine that is not registered.
  • The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
  • Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

  • A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
  • Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
  • Recent clinic notes and a list of current medicines
  • For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
  • Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for severe combined immunodeficiency (SCID)

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is there an FDA-approved treatment for severe combined immunodeficiency (SCID)?

Yes. The medicine on this page has US FDA approval for specific groups of patients: Revcovi. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Revcovi available in Saudi Arabia or the UAE?

Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Revcovi?

Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Can SCID be found at birth?

Yes. MedlinePlus Genetics explains that SCID can be detected shortly after birth by newborn screening, allowing prompt treatment. Ask whether your country's program includes it.

Does the enzyme medicine treat every type of SCID?

No. Revcovi's US label is only for ADA-SCID. Other types are usually treated with stem cell transplantation at specialized centers.

Sources for the last two answers: [1] [3]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

  1. MedlinePlus Genetics (US National Library of Medicine): X-linked severe combined immunodeficiency
  2. MedlinePlus Genetics (US National Library of Medicine): Adenosine deaminase deficiency
  3. DailyMed (US National Library of Medicine): Revcovi (elapegademase-lvlr) US prescribing information, version published 11 June 2026
  4. Al-Herz et al. The Kuwait National Primary Immunodeficiency Registry 2004-2018. Front Immunol 2019 (PubMed 31396239)
  5. SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
  6. Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
  7. SFDA: Special Access Program (SAP) guidance, version 1.0
  8. NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products

Related

This page is general health information, not medical advice. It does not replace a consultation with your doctor.

WhatsApp